More Amarantus Bioscience Holdings, Inc. news
Amarantus Bioscience Holdings, Inc.OTC: AMBS

Amarantus Subsidiary Elto Pharma Receives Notice of Allowance for European Patent Application Covering Method of Treating Cognitive Impairment Associated with Alzheimer’s Disease and Parkinson’s disea

Dec 7, 2017 · Issued by Amarantus Bioscience Holdings, Inc.

The original release is unavailable here.

Company analysis